NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 530 / 982

  1. Cannabinoid Hyperemesis2018 · Crossref
  2. Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline2018 · OpenAlex
  3. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases2018 · OpenAlex
  4. Cannabinoid ligands, receptors and enzymes: Pharmacological tools and therapeutic potential2018 · OpenAlex
  5. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System.2018 · PubMed
  6. Cannabinoid Type 1 Receptors Are Upregulated During Acute Activation of Brown Adipose Tissue2018 · OpenAlex
  7. Cannabinoids in cancer treatment: Therapeutic potential and legislation2018 · OpenAlex
  8. Cannabinoids in dermatology: a scoping review2018 · OpenAlex
  9. Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs2018 · OpenAlex
  10. Cannabinoids: from pot to lab2018 · OpenAlex
  11. Cannabis a "new" old medicine? - The challenges of its medical use in the XXI century2018 · Crossref
  12. Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity2018 · OpenAlex
  13. Cannabis and cannabinoid drug development: evaluating botanical versus single molecule approaches2018 · OpenAlex
  14. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies2018 · OpenAlex
  15. Cannabis and the Anxiety of Fragmentation—A Systems Approach for Finding an Anxiolytic Cannabis Chemotype2018 · OpenAlex
  16. Cannabis and the control of complexity2018 · Crossref
  17. Cannabis auf Rezept – Wunderpflanze Hanf2018 · Crossref
  18. Cannabis consumption and psychosis or schizophrenia development2018 · OpenAlex
  19. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects2018 · OpenAlex
  20. Cannabis for Chronic Pain: Challenges and Considerations2018 · OpenAlex
  21. Cannabis hyperemesis syndrome2018 · Crossref
  22. Cannabis in der Schmerztherapie – ein Jahr Cannabisgesetz2018 · Crossref
  23. Cannabis kann den Opioid-Missbrauch nicht bremsen2018 · Crossref
  24. Cannabis Prevalence and National Drug Policy in 27 Countries: An Analysis of Adolescent Substance Use2018 · Crossref
  25. Cannabis regulatory science: risk–benefit considerations for mental disorders2018 · OpenAlex
  26. Cannabis sativa Increases Seizure Severity and Brain Lipid Peroxidation in Pentylenetetrazole-Induced Kindling in Rats2018 · Crossref
  27. Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer.2018 · PubMed
  28. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history.2018 · PubMed
  29. CANNABIS SATIVA: ASPECTOS RELACIONADOS AO CONSUMO DE MACONHA NO CONTEXTO BRASILEIRO2018 · Crossref
  30. Cannabis smoking impairs driving performance on the simulator and real driving: a randomized, double‐blind, placebo‐controlled, crossover trial2018 · OpenAlex
  31. Cannabis Therapeutics and the Future of Neurology2018 · OpenAlex
  32. Cannabis use and driving-related performance in young recreational users: a within-subject randomized clinical trial2018 · OpenAlex
  33. Cannabis Use and Fetal Growth in Pregnant Women With Diabetes [18L]2018 · Crossref
  34. Cannabis use and suicide attempts among 86,254 adolescents aged 12–15 years from 21 low- and middle-income countries2018 · OpenAlex
  35. Cannabis Use and Supply Patterns Among Belgian Cannabis Social Club Members2018 · Crossref
  36. Cannabis use as harm reduction in the Eastern Caribbean2018 · Crossref
  37. Cannabis Use in an English Community2018 · OpenAlex
  38. CANNABIS USE INCREASES RISK FOR REVISION AFTER TOTAL KNEE ARTHROPLASTY2018 · OpenAlex
  39. Cannabis use is associated with lower rates of initiation of injection drug use among street‐involved youth: A longitudinal analysis2018 · Crossref
  40. Cannabis use precedes psychosis symptoms in teens2018 · Crossref
  41. Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample2018 · OpenAlex
  42. Cannabis utilisé à des fins non-médicales: Feu vert pour des essais pilotes ciblés?2018 · Crossref
  43. Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?2018 · OpenAlex
  44. Cannabis-based medicine: what is it good for?2018 · Crossref
  45. Cannabis-based medicines for chronic neuropathic pain in adults2018 · OpenAlex
  46. Cannabis‐based products for pediatric epilepsy: A systematic review2018 · OpenAlex
  47. Caracterização inorgânica da Ayahuasca e avaliação do seu potencial psicoterapêutico2018 · OpenAlex
  48. Carbonyl emissions from a novel heated tobacco product (IQOS): comparison with an e‐cigarette and a tobacco cigarette2018 · Crossref
  49. Carcinogen Exposure among Canadian Tobacco Users: Changes in NNK Exposure from 2007–2009 through 2012–20132018 · Crossref
  50. Cardiac arrest after ibogaine intoxication2018 · OpenAlex
  51. Cardiac malformation risk slightly higher with exposure to methylphenidate in pregnancy2018 · Crossref
  52. Cardiovascular complications and related risk factors underlying opium consumption2018 · Crossref
  53. Cardiovascular disease models: A game changing paradigm in drug discovery and screening2018 · OpenAlex
  54. Care actions for family members of users of psychoactive substances: intentions/expectations2018 · Crossref
  55. Caring for Patients With Opioid Use Disorder: What Clinicians Should Know About Comorbid Medical Conditions2018 · OpenAlex
  56. Carl Jung and Bill Wilson 1945–19612018 · OpenAlex
  57. Cartoon Addiction and Executive Functioning in School Going Children2018 · Crossref
  58. Catalytic Homogeneous Asymmetric Hydrogenation: Successes and Opportunities2018 · OpenAlex
  59. Catecholamines alter the intrinsic variability of cortical population activity and perception2018 · OpenAlex
  60. Causal Network Modeling of the Determinants of Drinking Behavior in Comorbid Alcohol Use and Anxiety Disorder2018 · Crossref
  61. Causes of Death After Nonfatal Opioid Overdose2018 · OpenAlex
  62. CB1 receptor activation induces intracellular Ca2+ mobilization and 2-arachidonoylglycerol release in rodent spinal cord astrocytes2018 · OpenAlex
  63. CDC guide to preventing opioid overdose reinforces role of harm reduction2018 · Crossref
  64. Cell-Type-Specific Afferent Innervation of the Nucleus Accumbens Core and Shell2018 · OpenAlex
  65. Cerebral blood flow predicts differential neurotransmitter activity2018 · OpenAlex
  66. Ceremonial ‘Plant Medicine’ use and its relationship to recreational drug use: an exploratory study2018 · OpenAlex
  67. Challenges and Obstacles to Conducting Legal Research about Personal Drug Consumption (Minimum Doses) in Latin America2018 · Crossref
  68. Challenges and opportunities for implementation of substance misuse interventions in conflict-affected populations2018 · OpenAlex
  69. Challenges and Resources Available for Mothers in Opiate Recovery: A Qualitative Study2018 · Crossref
  70. Challenges in implementing opioid agonist therapy in Lebanon: a qualitative study from a user’s perspective2018 · OpenAlex
  71. Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation2018 · Crossref
  72. Change in DSM‐5 Alcohol Use Disorder Criteria Count and Severity Level as a Treatment Outcome Indicator: Results from a Randomized Trial2018 · Crossref
  73. Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion2018 · OpenAlex
  74. Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands2018 · OpenAlex
  75. Changes in consumption of opioid analgesics in Israel 2009 to 2016: An update focusing on oxycodone and fentanyl formulations2018 · Crossref
  76. Changes in default-mode network activity and functional connectivity as an indicator of psychedelic-assisted psychotherapy effectiveness2018 · OpenAlex
  77. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.2018 · PubMed
  78. Changes in health status predict changes in alcohol consumption in older adults: the Seniors-ENRICA cohort2018 · Crossref
  79. Changes in Psychological Need Fulfillment Over the Course of Treatment for Major Depressive Disorder2018 · Crossref
  80. Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013–20162018 · OpenAlex
  81. Changes in secondary metabolites, organic acids and soluble sugars during the development of plum fruit cv. ‘Furongli’ (Prunus salicina Lindl)2018 · Crossref
  82. Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-20162018 · OpenAlex
  83. CHANGES IN THE MARKET OF TOBACCO AND TOBACCO PRODUCTS IN POLAND DURING THE YEARS 2001-20162018 · Crossref
  84. Changes in the Sociodemographic Factors of Tobacco and Alcohol Consumption in Chinese Adolescents from 2004 to 20112018 · Crossref
  85. Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine.2018 · PubMed
  86. Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016.2018 · PubMed
  87. Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan2018 · OpenAlex
  88. Changing student attitudes and perceptions toward opioid use disorder2018 · OpenAlex
  89. Characteristics and Patterns of Marijuana Use in Community‐Dwelling Older Adults2018 · OpenAlex
  90. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder2018 · Crossref
  91. Characteristics of cannabis cultivation in New Zealand and Israel2018 · Crossref
  92. Characteristics of opioid‐maintained clients smoking fentanyl patches: The importance of confirmatory drug analysis illustrated by a case series and mini‐review2018 · OpenAlex
  93. Characteristics of patients expressing an interest in ketamine treatment: results of an online survey2018 · OpenAlex
  94. Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State2018 · OpenAlex
  95. Characteristics of Patients With Opioid Use Disorder Associated With Performing Overdose Reversals in the Community: An Opioid Treatment Program Analysis2018 · OpenAlex
  96. Characteristics of Pregnant Women Reporting Cannabis Use Disorder at Substance Use Treatment Entry2018 · Crossref
  97. Characteristics of Tianeptine Exposures Reported to the National Poison Data System — United States, 2000–20172018 · OpenAlex
  98. Characterization of an acidic α-galactosidase from hemp (Cannabis sativa L.) seeds and its application in removal of raffinose family oligosaccharides (RFOs)2018 · Crossref
  99. Characterization of Behavioral, Signaling and Cytokine Alterations in a Rat Neurodevelopmental Model for Schizophrenia, and Their Reversal by the 5-HT6 Receptor Antagonist SB-3998852018 · OpenAlex
  100. Characterization of coffee cultivars leaf rust-resistant subjected to framework pruning2018 · Crossref